Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated
Adult
Case-Control Studies
Diabetes Mellitus
/ drug therapy
Female
Gastric Emptying
/ drug effects
Humans
Insulin Secretion
/ drug effects
Male
Meals
Metabolic Networks and Pathways
/ drug effects
Mutation, Missense
Postprandial Period
/ drug effects
Potassium Channels, Inwardly Rectifying
/ genetics
Sulfonylurea Compounds
/ therapeutic use
Young Adult
SU (Sulfonylurea)
insulin secretion
permanent Neonatal Diabetes
physiology
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
06
2019
revised:
06
09
2019
accepted:
11
11
2019
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
1
9
2020
Statut:
epublish
Résumé
Insulin secretion in sulfonylurea-treated 5 adults with sulfonylurea-treated In controls, glucose values after carbohydrate and protein/fat were similar (median glucose tAUC Individuals with sulfonylurea-treated NCT02921906.
Identifiants
pubmed: 31908791
doi: 10.1136/bmjdrc-2019-000721
pii: bmjdrc-2019-000721
pmc: PMC6936449
doi:
Substances chimiques
Kir6.2 channel
0
Potassium Channels, Inwardly Rectifying
0
Sulfonylurea Compounds
0
Banques de données
ClinicalTrials.gov
['NCT02921906']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e000721Subventions
Organisme : Diabetes UK
ID : 16/0005407
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105636/Z/14/Z
Pays : United Kingdom
Organisme : Department of Health
ID : ICA-SCL-2016-02-003
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098395/Z/12/Z
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR-HCS-P12-03-03
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110082/Z/15/Z
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
N Engl J Med. 2004 Apr 29;350(18):1838-49
pubmed: 15115830
Nat Neurosci. 2001 May;4(5):507-12
pubmed: 11319559
Diabetes. 2004 Oct;53(10):2542-51
pubmed: 15448082
Diabetes. 2004 Dec;53 Suppl 3:S181-9
pubmed: 15561909
Pediatr Diabetes. 2018 May;19(3):393-397
pubmed: 29205704
J Biol Chem. 2004 Apr 2;279(14):13393-401
pubmed: 14736887
Diabetes Care. 2013 Dec;36(12):3897-902
pubmed: 24170749
Brain Res. 1998 Dec 14;814(1-2):41-54
pubmed: 9838037
Diabetes. 1978 Apr;27(4):370-6
pubmed: 346423
Diabetes. 2005 Jun;54(6):1808-15
pubmed: 15919803
Diabetes. 2013 May;62(5):1612-22
pubmed: 23382449
Riv Eur Sci Med Farmacol. 1991 Sep-Dec;13(5-6):205-9
pubmed: 1819847
Diabetes Res Clin Pract. 2011 Dec;94(3):449-55
pubmed: 21955958
Nutr Metab (Lond). 2016 Aug 30;13(1):59
pubmed: 27582778
Diabetes. 2006 Dec;55 Suppl 2:S16-23
pubmed: 17130640
Diabetes. 2013 May;62(5):1391-3
pubmed: 23613562
Lancet. 2015 Sep 5;386(9997):957-63
pubmed: 26231457
Recent Prog Horm Res. 1967;23:617-62
pubmed: 4876487
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646
pubmed: 29880308
Acta Biochim Biophys Sin (Shanghai). 2013 Jan;45(1):36-43
pubmed: 23212075
PLoS Biol. 2007 Jun;5(6):e143
pubmed: 17503968
J Pediatr. 2006 Jul;149(1):47-52
pubmed: 16860127
Mol Metab. 2018 Nov;17:17-27
pubmed: 30146176
N Engl J Med. 2006 Aug 3;355(5):467-77
pubmed: 16885550
N Engl J Med. 2006 Aug 3;355(5):456-66
pubmed: 16885549